Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases - Some answers and still many questions.

Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases - Some answers and still many questions.

Item
http://www.wikidata.org/entity/Q40757066
The Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Systematic Review and Meta-Analysis.Risk burdens of modifiable risk factors incorporating lipoprotein (a) and low serum albumin concentrations for first incident acute myocardial infarction.PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016.Lipoprotein(a) and inhibitors of proprotein convertase subtilisin/kexin type 9.Asymmetric dimethylarginine and all-cause mortality: a systematic review and meta-analysis.Re-calibration of coronary risk prediction: an example of the Seven Countries Study.Pathophysiology of Long Non-coding RNAs in Ischemic Stroke.Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study
P2860

Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases - Some answers and still many questions.

Item
http://www.wikidata.org/entity/Q40757066
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Evidence-based assessment of l ...... wers and still many questions.
@en
type
label
Evidence-based assessment of l ...... wers and still many questions.
@en
prefLabel
Evidence-based assessment of l ...... wers and still many questions.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Evidence-based assessment of l ...... wers and still many questions.
@en
P2093
P2860
P304
P31
P356
10.1080/10408363.2016.1188055
P433
P478
P50
P577
P698
P921